Cyprien Mbogning

Statistics

Publications

Citations

256

H-Index

Active since

2013

Affiliations

Centre de recherche en Epidémiologie et Santé des Populations(Current)

Université Paris-Sud

Université Paris-Saclay

Université de Versailles Saint-Quentin-en-Yvelines

Inserm

Cyprien Mbogning is an author at Centre de recherche en Epidémiologie et Santé des Populations specializing in biostatistics, life sciences, and survival modeling.

ORCID

Publications per year

2013–2019

Publications

Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis

Jocelyn Quistrebert, Signe Hässler, Delphine Bachelet et al. · Seminars in Arthritis and Rheumatism · 2018 · 56 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis

Delphine Bachelet, Signe Hässler, Cyprien Mbogning et al. · PLoS ONE · 2016 · 40 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

Jenny Link, Ryan Ramanujam, Michael Auer et al. · PLoS ONE · 2017 · 39 citations · Full text

Medicine, Neurology, Pharmacology +12

An improved SAEM algorithm for maximum likelihood estimation in mixtures of non linear mixed effects models

Marc Lavielle, Cyprien Mbogning · Statistics and Computing · 2013 · 32 citations · Full text

Business, Biostatistics, Optimization +8

Joint modelling of longitudinal and repeated time-to-event data using nonlinear mixed-effects models and the stochastic approximation expectation–maximization algorithm

Cyprien Mbogning, Kevin Bleakley, Marc Lavielle · Journal of Statistical Computation and Simulation · 2014 · 23 citations · Full text

Business, Biostatistics, Statistical Modeling +15

1–5 of 9